iSperm Medical is a pioneering medical technology company dedicated to advancing reproductive medicine through innovation. We specialize in the integration of microfluidic technology, point-of-care testing (POCT), and AI-driven morphological analysis to deliver smart, efficient, and accessible fertility diagnostic solutions.
Our R&D team developed China's first home-use CASA system in 2017, and the first fully automated CASA system in 2018—marking significant milestones in the evolution of reproductive diagnostics. Our veterinary semen analyzer technology has revolutionized animal reproduction research and diagnostics in China.
At iSperm, our mission is to reshape the future of fertility diagnostics with intelligent, user-centric technologies—empowering better health outcomes, supporting reproductive journeys, and contributing to the future of life itself. We are committed to advancing fully automated CASA system technology for comprehensive semen analysis and sperm analyzer applications.
iSperm's AI-driven compact fully automated CASA system for human fertility and semen analysis is coming soon in late 2025.